Rexahn Pharmaceuticals Announce IND Submission for RX-3117
July 15 2013 - 7:00AM
Business Wire
RX-3117 has potential to treat a wide variety
of solid tumors including colon, lung, renal and pancreatic
tumors
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Rexahn Pharmaceuticals, Inc. (American Stock Exchange): 0 recent articles
More Rexahn Pharmaceuticals, Inc. News Articles